OTHER INCOME (EXPENSE), NET



	Three Months Ended September 30,		Nine Months Ended September 30,
	2018	2017	2018	2017
	(In thousands)
Other income (expense), net	$8,113	$(10,216)	$174,635	$(7,700)

Other income (expense), net consists of:

Three months ended September 30, 2018 and 2017

Other income, net in 2018 includes: $8.1 million of interest income; $0.8 million in net foreign currency exchange gains due primarily to the strengthening of the dollar relative to the British Pound; $0.7 million in realized gains related to the sales of certain investments; and $0.8 million mark-to-market charge pertaining to a subsidiary denominated equity instrument.

Other expense, net in 2017 includes: $10.2 million in net foreign currency exchange losses due primarily to the weakening of the dollar relative to the British Pound and Euro; $2.9 million in other-than-temporary impairment charges related to certain cost method investments; $2.1 million expense related to the repricing of the Match Group Term Loan; $1.5 million mark-to-market charge pertaining to a subsidiary denominated equity award held by a non-employee; $4.5 million in realized gains related to the sales of certain investments; and $2.9 million of interest income.

Nine months ended September 30, 2018 and 2017

Other income, net in 2018 includes: $126.4 million of net unrealized gains related to certain equity investments that were adjusted to fair value in accordance with ASU No. 2016-01, which was adopted on January 1, 2018; $27.9 million in realized gains related to the sale of certain equity investments; $20.2 million of interest income; $2.9 million in net foreign currency exchange gains due primarily to the strengthening of the dollar relative to the British Pound; and $1.3 million mark-to-market charge pertaining to a subsidiary denominated equity instrument.

Other expense, net in 2017 includes: $16.3 million in net foreign currency exchange losses due primarily to the weakening of the dollar relative to the British Pound and Euro; $12.2 million mark-to-market charge pertaining to a subsidiary denominated equity award held by a non-employee; $7.7 million in other-than-temporary impairment charges related to certain cost method investments; $2.1 million expense related to the repricing of the Match Group Term Loan; $1.2 million loss from the sale of The Princeton Review; $25.8 million in realized gains related to the sale of certain investments; and $7.1 million of interest income.